Complimentary, virtual event focuses on food as medicine
Osher Center for Integrative Health hosts free event with medical director Mladen Golubic, MD, PHD
Event Information (passed)
No matter your current eating pattern or nutritional philosophy, if you want to obtain the biggest nutritional bang for your buck, you would be wise to eat more vegetables and fruits. These groups of plants, along with beans and whole grains, contain vitamins and minerals and a spectrum of health-promoting, biologically active nutritional compounds generally called phytonutrients that mediate “Food as Medicine” positive effects on our health.
Join the Osher Center for Integrative Health at UC and Medical Director Mladen Golubic, MD, PHD for a complimentary, virtual class including:
- The key mechanisms by which these phytonutrients mediate “Food as Medicine” positive effects on our health
- Reveal how you can start craving these foods
- How to maximize these foods' health benefits by paying attention to how plants are grown, how fresh they are, and how they are stored and prepared.
About Mladen Golubic, MD, PHD
Mladen Golubic, MD, PhD serves as the Medical Director for the Osher Center for Integrative Health at UC and is an exceptional leader in the fields of lifestyle and integrative medicine. As an internist, Golubic has practiced and directed educational and research activities within integrative and lifestyle medicine since 2009 with a group of exceptional lifestyle medicine professionals (dietitians, chefs, yoga instructors, exercise physiologists, meditation teachers, etc.) within the Wellness Institute at the Cleveland Clinic. His clinical work focuses now on lifestyle-related chronic diseases.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Designing with cancer patients' needs in focus
August 27, 2026
Kristina Shin is designing garments that prioritize the comfort, function and confidence of breast cancer patients, addressing a need often overlooked by traditional fashion.